{"disease":{"id":"pneumonia-hospital-acquired","name":"pneumonia hospital acquired"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05979545","title":"EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":1900,"lead_sponsor_name":"National University of Singapore","has_results":false},{"nct_id":"NCT07004049","title":"Optimising TREATment for Severe Gram-Negative Bacterial Infections","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"National University of Singapore","has_results":false},{"nct_id":"NCT03121690","title":"The Applicability of Different Scoring Systems and Use of Steroids in the Treatment of Hospital Acquired Pneumonia","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07011433","title":"Pneumonia Pathogens' Virulence Factors, Patient Inflammatory Markers, and Their Associations With Outcomes","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":300,"lead_sponsor_name":"Ruta Nutautiene","has_results":false},{"nct_id":"NCT03032380","title":"Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Shionogi","has_results":true},{"nct_id":"NCT06867458","title":"Steriwave ICU Pilot Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":227,"lead_sponsor_name":"Fraser Health","has_results":false},{"nct_id":"NCT05624684","title":"Diagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia.","phase":"","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"Avicenna Military Hospital","has_results":false},{"nct_id":"NCT02714595","title":"Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Shionogi","has_results":true},{"nct_id":"NCT03439124","title":"Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":138,"lead_sponsor_name":"Basilea Pharmaceutica","has_results":true},{"nct_id":"NCT04700202","title":"Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit","phase":"","overall_status":"COMPLETED","enrollment_count":132,"lead_sponsor_name":"Methodist Health System","has_results":false},{"nct_id":"NCT03496220","title":"Effect of Angulus on Patient-elevation Compliance","phase":"NA","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Angulus, LLC","has_results":true},{"nct_id":"NCT06062862","title":"Effect of Breather on Hospital Stay in Patients With Acquired Pneumonia","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT05785442","title":"Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Hellenic Institute for the Study of Sepsis","has_results":false},{"nct_id":"NCT07397364","title":"Impact of Nurses' Behavior Change and Evidence-Based Practice Implementation on Quality Indicators in Intensive Care Units in Low- and Middle-Income Countries","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT05214716","title":"FilmArray Pneumonia Panel for Antimicrobial Treatment of HAP/VAP in Intensive Care Units","phase":"NA","overall_status":"TERMINATED","enrollment_count":41,"lead_sponsor_name":"Kyungmin Huh","has_results":false},{"nct_id":"NCT05663905","title":"Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"National University of Malaysia","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}